Mechanisms underlying the antifibrotic properties of noninhibitory PAI-1 (PAI-1R) in experimental nephritis. - Wikidata - wikimedia - TriplyDB

Mechanisms underlying the antifibrotic properties of noninhibitory PAI-1 (PAI-1R) in experimental nephritis.

Mechanisms underlying the antifibrotic properties of noninhibitory PAI-1 (PAI-1R) in experimental nephritis.

http://www.wikidata.org/entity/Q37417240

about

Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/beta-catenin signaling.Vitronectin accumulates in the interstitium but minimally impacts fibrogenesis in experimental chronic kidney disease Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice.A plasminogen activator inhibitor type 1 mutant retards diabetic nephropathy in db/db mice by protecting podocytes Abrogation of plasminogen activator inhibitor-1-vitronectin interaction ameliorates acute kidney injury in murine endotoxemia.Therapeutic potential of an orally effective small molecule inhibitor of plasminogen activator inhibitor for asthma.uPA binding to PAI-1 induces corneal myofibroblast differentiation on vitronectin.Therapeutic potential of plasminogen activator inhibitor-1 inhibitors.This is not Dr. Conn's aldosterone anymore.Challenging delivery of VLHL NS plasminogen activator inhibitor-1 by osmotic pumps in diabetic mouse: A case report.Plasminogen activator inhibitor-1 antisense oligodeoxynucleotides abrogate mesangial fibronectin accumulation.

P2860

Q26779846-E953D786-C96F-4045-9BE2-CA74FFECD0DC Q34042645-B0992BD7-BB13-40A6-9762-0955506C1338 Q34979663-A1F7D715-D5C1-49DB-BDBC-3D4DD586677F Q35180538-5D35DCD6-9483-4C5E-AD84-74803BC82F9A Q35182731-9EC523EB-A8B4-4906-8737-DB44206E94CC Q35185276-F4BE8E72-1F2D-4333-ABE9-F66A6B664A20 Q35584207-965488C8-92F0-4A86-82B0-4FCA9DC48170 Q36583859-44C5AA6E-22A7-4F52-B078-27DE062C61D6 Q37629834-AD02ED66-BA5B-4B29-86B6-938B5E5778F7 Q37775818-97FD4AFE-CD19-4E47-9544-6F101B91F9F2 Q37891697-7542D80D-4CAA-4D77-A5D6-77DADB3952B1 Q41493665-E06EBD16-67AB-49F4-908B-71C37B21681B Q41966543-B57F204C-A02C-4BE3-8665-EAF8C83F08C7

P2860

Mechanisms underlying the antifibrotic properties of noninhibitory PAI-1 (PAI-1R) in experimental nephritis.

http://www.wikidata.org/entity/Q37417240

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Mechanisms underlying the anti ...... 1R) in experimental nephritis.

@en

Mechanisms underlying the antifibrotic properties of noninhibitory PAI-1

@nl

type

label

Mechanisms underlying the anti ...... 1R) in experimental nephritis.

@en

Mechanisms underlying the antifibrotic properties of noninhibitory PAI-1

@nl

prefLabel

Mechanisms underlying the anti ...... 1R) in experimental nephritis.

@en

Mechanisms underlying the antifibrotic properties of noninhibitory PAI-1

@nl

P1433

Q37417240-AA2E54E2-4585-409C-91F7-05F9DE34EB30

P1476

Q37417240-90DE3420-F48D-47CD-873C-0E1BF465CBD4

P2093

Q37417240-0473D40D-21BA-4700-92A0-6CAD13AED768

Q37417240-7936A680-09AD-4BFD-83E9-50BD1D3E0BEC

Q37417240-CDEA3265-F45D-4D5C-AFA9-E4D0806E4F6D

Q37417240-FFD8AF6B-516D-4625-AB70-8BF72D4708BD

P2860

Q37417240-099BEDDC-133B-4987-8B6B-F36406AFE1D2

Q37417240-0B313717-039D-40BF-AA95-9672E1D416D7

Q37417240-10B9EE45-9329-4CCC-8048-C90AD5B2DE86

Q37417240-215CE009-294B-4838-ABCA-80AE7D48C053

Q37417240-329D42D3-A420-42CC-A945-4FD5595BAE85

Q37417240-32D77C4F-623D-4D62-835D-855E5DE9607E

Q37417240-358E843A-E180-4BCB-9367-25A5AC63CA33

Q37417240-3AE9789C-31FE-4A5B-82A1-95483E8EDA80

Q37417240-6097684E-6808-4FA0-8A10-B70074773CC6

Q37417240-6282B24B-DA22-4B0A-9C2B-38A39E8A5A6F

P304

Q37417240-7ED8220D-70F8-4901-80FD-4DF2CE40B947

P31

Q37417240-994023B4-983E-48F3-B4B0-ABC3666E2401

P356

Q37417240-D5AF9C8C-DDD1-4348-AC77-1DD48E710C3E

P433

Q37417240-4CA0C122-462C-4C77-84DE-F67F029379CC

P478

Q37417240-27FFF42A-9533-4327-8676-AC361D48B84A

P577

Q37417240-A45432C7-F593-442A-A75F-4C7BCF76F923

P698

Q37417240-AF2E62D6-2E92-4A79-86AF-C50F6E1F22CB

P932

Q37417240-3A8DAF61-B716-4645-91AB-5A5FBBE24B2B

P356

AJPRENAL.00024.2009

P1433

American Journal of Physiology - Renal Physiology

P1476

Mechanisms underlying the anti ...... 1R) in experimental nephritis.

@en

P2093

Daniel A Lawrence

http://www.w3.org/2001/XMLSchema#string

Nancy A Noble

http://www.w3.org/2001/XMLSchema#string

Wayne A Border

http://www.w3.org/2001/XMLSchema#string

Yufeng Huang

http://www.w3.org/2001/XMLSchema#string

P2860

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration

High-resolution structure of the stable plasminogen activator inhibitor type-1 variant 14-1B in its proteinase-cleaved form: A new tool for detailed interaction studies and modeling

Vitronectin is not essential for normal mammalian development and fertility.

Matrix metalloproteinase system deficiencies and matrix degradation.

Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: possible role in diabetic nephropathy.

Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?

Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action.

A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathy

Molecular evolution of plasminogen activator inhibitor-1 functional stability

P304

F1045-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPRENAL.00024.2009

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

297

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19625379

http://www.w3.org/2001/XMLSchema#string

P932

2775568

http://www.w3.org/2001/XMLSchema#string